ArticleNature machine intelligence2022
Dual Use of Artificial Intelligence-powered Drug Discovery.
Article in Nature machine intelligence, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 94 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
94 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Definitional ambiguity in cognitive warfare: a critical and systematic conceptual review through ideal-type analysis.Frontiers in big data · 2026Pooled it
- Mapping knowledge landscapes and emerging trends in artificial intelligence for antimicrobial resistance: bibliometric and visualization analysis.Frontiers in medicine · 2025Pooled it
- Cyber-biological convergence: a systematic review and future outlook.Frontiers in bioengineering and biotechnology · 2024Pooled it
- The rise of agentic AI in drug discovery from static tools to autonomous virtual scientists.npj drug discovery · 2026Review
- Multimodal learning enables chat-based exploration of single-cell data.Nature biotechnology · 2026Article
- Advances in detecting category A biothreat agents: Toward symptom-driven sensing strategies.Synthetic and systems biotechnology · 2026Review
- Enhanced classification and identification of bacterial and viral microorganisms by integration of MALDI-TOF mass spectrometry with artificial intelligence.Scientific reports · 2026Article
- Censoring chemical data to mitigate dual use risk.Digital discovery · 2026Article
- Article
- XGBPred-ACSM: A Hybrid Descriptor-Driven XGBoost Framework for Anticancer Small Molecule Prediction.Pharmaceuticals (Basel, Switzerland) · 2026Article
- General-Purpose Models for the Chemical Sciences: LLMs and Beyond.Chemical reviews · 2026Review
- Review
- Article
- China's regulatory regime for medical biotechnology: evolution, challenges, and future perspectives.Frontiers in medical technology · 2026Review
- Red-teaming as an imperative for strengthening synthetic nucleic acid screening.Frontiers in bioengineering and biotechnology · 2026Review
- A high-throughput screening platform for acetylcholinesterase inhibitors using a genetically encoded acetylcholine fluorescent sensor.Frontiers in bioengineering and biotechnology · 2026Article
- Human CYP2C9 Metabolism of Organophosphorus Pesticides and Nerve Agent Surrogates.Journal of xenobiotics · 2025Article
- CRISPR Treatments for AI-Designed Synthetic Viruses: Rapid Programmable Countermeasures for Emerging and Engineered Viruses.Viruses · 2025Review
- Nanodiamond mediated delivery of pyridinium oxime antidotes to central nervous system for potential treatment of exposure to nerve agents.Chemico-biological interactions · 2025Article
- Large language models for drug discovery and development.Patterns (New York, N.Y.) · 2025Review
34 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
An international security conference explored how artificial intelligence (AI) technologies for drug discovery could be misused for de novo design of biochemical weapons. A thought experiment evolved into a computational proof.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.